A preprint study found that nearly a third of people with COVID-19 experienced rebound symptoms and 12% tested positive again, regardless of whether they’d taken Paxlovid.
Around a third of people with COVID-19 will experience a rebound of their symptoms, regardless of whether they’ve been treated with the antiviral Paxlovid, according to aThe preprint study — meaning it hasn’t been published in a peer-reviewed journal — found that 27% of people with COVID-19 saw a rebound in their symptoms after they had initially improved.
“It happens all the time. People who are untreated with COVID who then feel better can get symptoms afterward,” said study co-author Dr. Davey Smith, chief of infectious diseases and global public health at the University of California, San Diego School of Medicine. Still, Smith noted the that 27% finding was higher than what he’d expected based on anecdotal evidence.
The study also found that 12% of people with COVID-19 had a “viral rebound,” meaning they tested positive again several days after testing negative. This has been documented among people who have taken Paxlovid and is referred to as, but the study found that viral rebound occurred regardless of whether a person had taken the antiviral treatment.
Anyone who has had COVID-19 could see a return of symptoms after they’ve initially gone away, and those symptoms could be worse or not as bad as the first bout, Smith said. “It’s just the variability in the natural course of the infection.” The Centers for Disease Control and Prevention has acknowledged the possibility of symptom recurrence in untreated Covid patients. When the agency in May issued ainforming physicians about Paxlovid rebounds, it also said that “a brief return of symptoms may be part of the natural history of SARS-CoV-2 infection in some persons, independent of treatment with Paxlovid and regardless of vaccination status.”“In some ways, that’s the natural history of all respiratory viral infections,” said Dr.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
What You Need to Know About Rebound COVID-19 After PaxlovidPlus, how often it really happens.
Weiterlesen »
'DC Health Announces Telehealth Antiviral Treatment Program (Paxlovid) for COVID-19'photo by Radio Alfa From DC Health: 'Today, DC Health announced a new partnership with Color Health to offer a free COVID-19 treatment access program via
Weiterlesen »
Covid can rebound even in people who haven’t taken Paxlovid, study findsA preprint study found that nearly a third of people with Covid experienced rebound symptoms and 12% tested positive again, regardless of whether they'd taken Paxlovid.
Weiterlesen »
Evusheld for COVID-19: Lifesaving and Free, but Still Few TakersThe monoclonal antibody is an available, highly effective preventive medication for millions of immunocompromised people, yet many patients ― and even some doctors ― are unaware of it or are unable to get it.
Weiterlesen »
Biden's latest COVID-19 'rebound' case has researchers evaluating link to anti-viral drugHealth experts say during clinical trials, rebound cases happened in only 1 to 2% of people.
Weiterlesen »
Biden has COVID-19: Political CartoonsCheck out our regular cartoon gallery featuring some of the best cartoonists from around the world, and across the political spectrum, covering current issues and figures.
Weiterlesen »